New drug combo aims to stop advanced breast Cancer's repair system
NCT ID NCT03742245
Summary
This early-stage trial is testing whether two existing drugs, olaparib and vorinostat, can be safely used together to treat advanced breast cancer that has returned or spread. The study aims to find the safest dose and see if blocking two of the cancer's repair mechanisms helps control the disease. It involves adults with metastatic breast cancer who have exhausted other options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Houston Methodist Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.